ICON experts frequently author or contribute to industry trade press. The following are some recent articles.
Ready or Not, Medtech Braces For New EU Landscape
The EU's new Medical Device Regulation is set to take effect in May 2020 and the In Vitro Diagnostics Regulation two years later.
Using Economic Models to Gain Early Access
Early access schemes demand new ways of performing health economic evaluations. This means developing health economic models
What ICER Pricing Would Mean for U.S. Drug Spend
ICER has become a major force in payer–manufacturer price negotiations.
CROs Must Be Aware Of Threat Posed By Big Tech
ICON’s CEO Steve Cutler discusses the impact of biotech funding, disruptive tech providers, and the constant pressure of running one of the industry’s largest CROs.
Global Outsourcing Strategies
The market for pharmaceutical services outsourcing has grown to become a multi-billion dollar industry that encompasses a broad spectrum of outsourcing models
The Path To A Successful Digital Trial
There is a growing awareness in the healthcare sector of the benefit and value of a mHealth approach to healthcare.
Adaptive Designs: Smarter Development Programmes for Oncology
Parvin Fardipour and Alan Phillips review the different types of adaptive trial designs that have been deployed in oncology trials to good effect and more.
Stakeholder Dialogue in Europe’s Adaptive Pathways Pilot
The AP approach is designed for products in therapeutic areas of high unmet need and for which it may be difficult to generate clinical data via the regular route.
Challenges in Clinical Trials
Steve Cutler, outlines some of the challenges to successful clinical trials in this PharmaTimes artice.
Device Certification and Recertification
A three-step approach to identify products for compliance with the new MDR and IVDR.